Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
EntreMed Issued U.S. Patent For Active Parts Of Endostatin.
This article is from
The Cancer Letter
archive.
Vol. 27 No. 09 | March 2, 2001
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Alternative Medicine: Testing The Boundaries Of Science
May 15, 1998
TCL Archive
ONS Adopts Scope Of Oncology Nursing Practice
November 23, 1984
TCL Archive
Zevalin Regimen Better Than Rituximab Alone For NHL
June 29, 2001
TCL Archive
Becker, Brown Testify On Biomedical Funding, Manpower Needs
March 23, 1990
TCL Archive
NIH, NCI Get Higher Funding In 2014 Budget
January 17, 2014
TCL Archive
Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer
March 24, 1978